Mario Venditti

28PUBLICATIONS
91CO-AUTHORS
Medical infection agents (incl. prions)Predictive and prognostic markersMedical bacteriologyPlant and fungus systematics and taxonomyInfectious diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Feb 03, 2025
Are contemporary antifungal doses sufficient for critically ill patients? Outcomes from an international, multicenter pharmacokinetics study for Screening Antifungal Exposure in Intensive Care Units-the SAFE-ICU study.

Jason A Roberts, Fekade B Sime, Jeffrey Lipman

|Oct 26, 2024
Association Between NOX2-Mediated Oxidative Stress, Low-Grade Endotoxemia, Hypoalbuminemia, and Clotting Activation in COVID-19.

Roberto Carnevale, Cristina Nocella, Raffaella Marocco

|Jul 26, 2024
Short Course Antibiotic Therapy for Catheter-Related Septic Thrombosis: "Caveat Emptor!": Duration of Therapy Should Not Be Set a Priori.

Alberto Enrico Maraolo, Giancarlo Ceccarelli, Mario Venditti

|Dec 23, 2023
New Antimicrobials and New Therapy Strategies for Endocarditis: Weapons That Should Be Defended.

Alessandra Oliva, Francesco Cogliati Dezza, Francesca Cancelli

|Oct 14, 2023
Reduced Reliability of Procalcitonin (PCT) as a Biomarker of Bacterial Superinfection: Concerns about PCT-Driven Antibiotic Stewardship in Critically Ill COVID-19 Patients-Results from a Retrospective Observational Study in Intensive Care Units.

Giancarlo Ceccarelli, Francesco Alessandri, Giuseppe Migliara

|Jul 26, 2023
Invasive Candida infection: epidemiology, clinical and therapeutic aspects of an evolving disease and the role of rezafungin.

Alessandra Oliva, Francesco Giuseppe De Rosa, Malgorzata Mikulska

Pageof 5

Frequent Collaborators

14 joint publications

Alessandra Oliva

13 joint publications

Giancarlo Ceccarelli

6 joint publications

Alessandro Russo

6 joint publications

Claudio Mastroianni